Franklin Covey forecasts FY2026 revenue of $260M-$267M while maintaining adjusted EBITDA of $28M-$31M (NYSE:FC)July 2, 2026
Share Facebook Twitter LinkedIn Pinterest Email Urogen pharma outlines $1B revenue potential for UGN-102 with June 2025 launch target
Franklin Covey forecasts FY2026 revenue of $260M-$267M while maintaining adjusted EBITDA of $28M-$31M (NYSE:FC)July 2, 2026